New formulations and derivatives of Amphotericin B for treatment of leishmaniasis

Keyphrases

• Leishmaniasis 100%
• Amphotericin B 100%
• Toxic Effects 20%
• Immune Response 10%
• Adverse Effects 10%
• High Dose 10%
• Mode of Action 10%
• Elderly People 10%
• Clinical Treatment 10%
• Cholesterol 10%
• Hospital Costs 10%
• Human Use 10%
• Maximum Tolerated Dose 10%
• Pharmacokinetics 10%
• Immunomodulatory Effect 10%
• Slow Release 10%
• Liquid Solution 10%
• Nephrotoxicity 10%
• Lipid Component 10%
• Induced Resistance 10%
• Ergosterol 10%
• Reduced Toxicity 10%
• Lipid-based Formulation 10%
• Streptomyces Sp. 10%
• Number of Drugs 10%
• Clinical Resistance 10%
• Oral Treatment 10%
• Lipid Solubility 10%
• Antileishmanial Drugs 10%
• Multiple Visits 10%
• Polyene Antibiotics 10%
• Hospitalization Visits 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Leishmaniasis 100%
• Amphotericin B 100%
• Toxicity 20%
• Nephrotoxicity 10%
• Ergosterol 10%
• Pharmacokinetics 10%
• Adverse Event 10%
• Streptomyces 10%
• Polyene Antibiotic Agent 10%